NovaScan LLC is a Milwaukee based company founded in 2003 to commercialize breast cancer detection technology. Our mission is to provide the most cost effective and innovative noninvasive cancer detection devices to the medical community.  We believe the best way to achieve this goal is through partnership as evidenced in our close alliance and collaboration with Aurora Health Care in Milwaukee, WI.

Company Founders

William Gregory, PhD, CSO, Christopher Gregory, PhD, and Larry Wells.

Facts

NovaScan is the exclusive licensee for patents related to this technology from WiSys, a division of the Wisconsin Alumni Research Foundation (WARF).

NovaScan has developed an in-vivo (FastPath residual cancer probe) and ex-vivo (Electrical Mammogram) device to detect breast cancer (Brochure) or (Powerpoint Presentation).

FastPath Probe:  A hand held probe used by surgeons to detect malignant tissue remaining in the surgical cavity during surgery.

Electrical Mammogram:  Makes use of the NovaScan proprietary electrical scanning technology as an adjunct to traditional x-ray mammograms to produce a color image that depicts anomalies detected in extracted tissue.

Awards

2004

• Governors Business Plan Contest.

2006

• Governors Technology Transfer Award.

2008

• Innovator Award by WiSys and UW research foundation

2010

• National Science Foundation SBIR Grant Award
• Aurora Health Care Innovation Award.

2011

• New Technology Showcase Award, LifeScience Alley.

Partners/Alliances

Aurora Health Care, 750 W. Virginia St., P.O. Box 341880, Milwaukee, WI 53234.

Voith Consulting LLC, 9100 N. Swan Rd, Milwaukee, WI 53224.

Devicix LLC, 7680 Executive Dr, Eden Prairie, MN 55344.

Axcesor Inc., 2260 Dakota Drive, Grafton, WI, 53024-9574.